Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60.5M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
53.4M
-
Shares change
-
-1.99M
-
Total reported value, excl. options
-
$1.85B
-
Value change
-
-$79.1M
-
Put/Call ratio
-
0.64
-
Number of buys
-
105
-
Number of sells
-
-77
-
Price
-
$34.96
Significant Holders of Twist Bioscience Corp - Common Stock (TWST) as of Q2 2022
231 filings reported holding TWST - Twist Bioscience Corp - Common Stock as of Q2 2022.
Twist Bioscience Corp - Common Stock (TWST) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.4M shares
of 60.5M outstanding shares and own 88.36% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (6.27M shares), BlackRock Inc. (4.97M shares), VANGUARD GROUP INC (4.93M shares), STATE STREET CORP (3.82M shares), FMR LLC (3.57M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2.72M shares), Nikko Asset Management Americas, Inc. (2.68M shares), Sumitomo Mitsui Trust Holdings, Inc. (2.68M shares), Jackson Square Partners, LLC (2.5M shares), and MARSHALL WACE, LLP (2.06M shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.